The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A Placebo-Controlled Trial of Itopride in Functional Dyspepsia
Abstract
BACKGROUND: The treatment of patients with functional dyspepsia remains unsatisfactory. We assessed the efficacy of itopride, a dopamine D2 antagonist with anti-acetylcholinesterase [corrected] effects, in patients with functional dyspepsia. METHODS: Patients with functional dyspepsia were randomly assigned to receive either itopride (50, 100, or 200 mg three times daily) or placebo. After eight weeks of treatment, three primary efficacy end points were analyzed: the change from baseline in the severity of symptoms of functional dyspepsia (as assessed by the Leeds Dyspepsia Questionnaire), patients' global assessment of efficacy (the proportion of patients without symptoms or with marked improvement), and the severity of pain or fullness as rated on a five-grade scale. RESULTS: We randomly assigned 554 patients; 523 had outcome data and could be included in the analyses. After eight weeks, 41 percent of the patients receiving placebo were symptom-free or had marked improvement, as compared with 57 percent, 59 percent, and 64 percent receiving itopride at a dose of 50, 100, or 200 mg three times daily, respectively (P<0.05 for all comparisons between placebo and itopride). Although the symptom score improved significantly in all four groups, an overall analysis revealed that itopride was significantly superior to placebo, with the greatest symptom-score improvement in the 100- and 200-mg groups (-6.24 and -6.27, vs. -4.50 in the placebo group; P=0.05). Analysis of the combined end point of pain and fullness showed that itopride yielded a greater rate of response than placebo (73 percent vs. 63 percent, P=0.04). CONCLUSIONS: Itopride significantly improves symptoms in patients with functional dyspepsia. (ClinicalTrials.gov number, NCT00272103.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What are functional bowel disorders?
Zighelboim, J., & Talley, N. J. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90293-l · Cited by 46
Self-citation
Cited by
ACG and CAG Clinical Guideline: Management of Dyspepsia
Moayyedi, P. M., Lacy, B. E., Andrews, C. N., Enns, R. A., Howden, C. W., & Vakil, N. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.154 · Cited by 689
Review article: current treatment options and management of functional dyspepsia
Lacy, B. E., Talley, N. J., Locke, G. R., Bouras, E. P., DiBaise, J. K., El‐Serag, H. B., Abraham, B. P., Howden, C. W., Moayyedi, P., & Prather, C. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05128.x · Cited by 192
Self-citationRole of infection in irritable bowel syndrome
Spiller, R. C. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1925-8 · Cited by 187
Gastroparesis and Parkinson’s disease: a systematic review
Heetun, Z. S., & Quigley, E. M. M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.12.004 · Cited by 182
Dyspepsia: Organic Versus Functional
Oustamanolakis, P., & Tack, J. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318241b335 · Cited by 146
Metadata
- Authors
- Holtmann, G., Talley, N. J., Liebregts, T., Adam, B., & Parow, C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-02-23
- Volume
- 354
- Issue
- 8
- Pages
- 832-840
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2060277219
- Cited by
- 235
- References
- 1
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Placebo-Controlled Trial of Itopride in Functional Dyspepsia. https://app.cochat.ai/papers/10.1056/nejmoa052639
- The paper
- Holtmann, G., Talley, N. J., Liebregts, T., Adam, B., & Parow, C. (2006). A Placebo-Controlled Trial of Itopride in Functional Dyspepsia. New England Journal of Medicine. https://doi.org/10.1056/nejmoa052639
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.